Vladimir Makatsaria

“I think the way I would think about price holistically, you have our annual price increase and I think Livanova is very disciplined about that.”

“Well, Neha, first of all, thank you for the opportunity to join you, and thank you all for joining this morning and for your interest in Livanova. So for those of you new to the story, Livanova is a global medtech company with nearly 50 years of experience in some of the market-leading portfolios.”

“Before reviewing our strong quarterly performance, I would like to begin by recognizing something fundamental to Levin Nova's long-term success. Exceptional people deliver strong results.”

“So first of all, good morning, and David, thank you for the opportunity to be here, and thank you, everybody, for joining this early morning.”

“In the quarter, Levanova delivered 11% revenue growth with strength across all regions, driven by durable performance in our cardiopulmonary and epilepsy businesses our core businesses continue to serve as both the drivers of current performance and enablers of discipline investments and innovation we expect these…”